Need Physician Approval
Xalkori 250Mg Capsule
14,478.75
In stock
SKU :
104220
Targeted ALK/ROS1 lung cancer therapy
Product Description
Xalkori (crizotinib) 250mg Capsule is a targeted therapy for non-small cell lung cancer (NSCLC) with ALK or ROS1 gene rearrangements. It works by blocking signals that promote cancer cell growth.
Key Benefits
- Treats ALK+ or ROS1+ NSCLC
- Slows cancer progression
- Improves patient survival
- Oral targeted therapy
| Offer Label | Need Physician Approval |
|---|---|
| Shipping Type | Express |
Write Your Own Review
